BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10082239)

  • 1. Risperidone-induced rabbit syndrome: an unusual movement disorder caused by an atypical antipsychotic.
    Levin T; Heresco-Levy U
    Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):137-9. PubMed ID: 10082239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone-induced rabbit syndrome: an unusual movement disorder.
    Sansare K; Singh D; Khanna V; Karjodkar FR
    N Y State Dent J; 2012; 78(5):44-6. PubMed ID: 23082694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tardive dyskinesia following brief exposure to risperidone--a case study.
    Karama S; Lal S
    Eur Psychiatry; 2004 Sep; 19(6):391-2. PubMed ID: 15363485
    [No Abstract]   [Full Text] [Related]  

  • 4. Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature.
    Peritogiannis V; Tsouli S
    J Psychopharmacol; 2010 Jul; 24(7):1121-5. PubMed ID: 19395427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risperidone-induced tardive dyskinesia.
    Silberbauer C
    Pharmacopsychiatry; 1998 Mar; 31(2):68-9. PubMed ID: 9562211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withdrawal-emergent dyskinesia in a patient on risperidone undergoing dosage reduction.
    Anand VS; Dewan MJ
    Ann Clin Psychiatry; 1996 Sep; 8(3):179-82. PubMed ID: 8899136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone induced stuttering.
    Yadav DS
    Gen Hosp Psychiatry; 2010; 32(5):559.e9-10. PubMed ID: 20851282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone-induced hepatotoxicity.
    Benazzi F
    Pharmacopsychiatry; 1998 Nov; 31(6):241. PubMed ID: 9930641
    [No Abstract]   [Full Text] [Related]  

  • 9. Tardive dyskinesia following risperidone treatment in Tourette's syndrome.
    Thomas N; Swamidhas P; Russell S; Angothu H
    Neurol India; 2009; 57(1):94-5. PubMed ID: 19305093
    [No Abstract]   [Full Text] [Related]  

  • 10. Follow-up of a pregnancy with risperidone microspheres.
    Dabbert D; Heinze M
    Pharmacopsychiatry; 2006 Nov; 39(6):235. PubMed ID: 17124649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone-induced anxiety might also develop 'awakening' phenomenon.
    Hori M; Shiraishi H
    Psychiatry Clin Neurosci; 1999 Dec; 53(6):682. PubMed ID: 10687752
    [No Abstract]   [Full Text] [Related]  

  • 12. Risperidone-induced tardive dyskinesia.
    Bassitt DP; de Souza Lobo Garcia L
    Pharmacopsychiatry; 2000 Jul; 33(4):155-6. PubMed ID: 10958268
    [No Abstract]   [Full Text] [Related]  

  • 13. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
    Liu PY; Wu PC; Chen CY; Chen YC
    Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report.
    Mall GD; Hake L; Benjamin AB; Adityanjee A
    J Clin Psychopharmacol; 2008 Oct; 28(5):572-3. PubMed ID: 18794658
    [No Abstract]   [Full Text] [Related]  

  • 15. [The risperidone-associated neuroleptic malignant syndrome in a pediatric patient].
    Villanueva Lamas J; García García J; Alda Diez JA; Tous Andreu N
    An Esp Pediatr; 1998 Dec; 49(6):652-3. PubMed ID: 9972639
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone.
    Nelson MW; Reynolds RR; Kelly DL; Conley RR
    Clin Neuropharmacol; 2003; 26(6):297-8. PubMed ID: 14646608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic-induced rabbit syndrome: epidemiology, management and pathophysiology.
    Schwartz M; Hocherman S
    CNS Drugs; 2004; 18(4):213-20. PubMed ID: 15015902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
    Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine treatment in patients with typical and atypical neuroleptic-associated agranulocytosis.
    Finkel B; Lerner A; Oyffe I; Rudinski D; Sigal M; Weizman A
    Int Clin Psychopharmacol; 1998 May; 13(3):133-5. PubMed ID: 9690981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone and tardive dyskinesia in organic psychosis.
    Fischer P; Tauscher J; Küfferle B
    Pharmacopsychiatry; 1998 Mar; 31(2):70-1. PubMed ID: 9562212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.